Twin Focus Capital Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Twin Focus Capital Partners's LLY Position: Q1 2026 in Review
Twin Focus Capital Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 359 shares — an estimated $386K sold.
Twin Focus Capital Partners first reported a position in LLY in Q4 2020 and held it in 21 quarters. The position peaked at $616K in Q2 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Twin Focus Capital Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
- Twin Focus Capital Partners sold 359 Eli Lilly shares in Q1 2026, an estimated $386K.
- Twin Focus Capital Partners first reported a position in Eli Lilly in Q4 2020 and held it in 21 quarters.
- Twin Focus Capital Partners's Eli Lilly position peaked at $616K in Q2 2023.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Twin Focus Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.